The global biosensors market was valued at $14,169.5 million in 2015, and it is expected to grow at a CAGR of 9.8% during 2016-2022. Based on application, the environment segment is expected to witness the fastest growth, CAGR of 11.5%, during the forecast period.

The global biosensors market is growing at a significant rate, due to increasing prevalence of diabetes and growing geriatric population. The increasing prevalence of chronic and lifestyle associated diseases, increasing demand for point of care testing and increasing application of biosensors in various industries are also driving the growth of the global biosensors market. However, factors such as strict regulatory requirement and reimbursement policy issues in healthcare systems are inhibiting the growth of the global market.

Explore Report with Detailed TOC on “Global Biosensors Market” at: https://www.psmarketresearch.com/market-analysis/biosensors-market

Geographically, North America dominated the global market of biosensors in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth, CAGR of 11.3%, during the forecast period.

Some of the key companies operating in the global biosensors market include Siemens AG, LifeSensors, Inc., Nova Biomedical Corporation, Abbott Laboratories, Inc., Johnson & Johnson, Medtronic, PLC, I-SENS, Inc., F. Hoffmann La Roche, TaiDoc Technology Corporation, and ACON Laboratories, Inc.

Make enquiry before buying the report:
https://www.psmarketresearch.com/send-enquiry?enquiry-url=biosensors-market